Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA), a leader in innovative drug development and a vocal advocate for reducing ...
FDA’s NAM framework emphasizes context of use, human biological relevance, technical characterization, and fit-for-purpose ...
Early 2026 has brought a series of consequential regulatory moves from the FDA, each reflecting a common thread: the agency ...
The FDA has released a draft guidance outlining how drug developers can validate new approach methodologies (NAMs) as ...
Health authorities in the U.S. are continuing their move away from animal testing in drug development, with the FDA signaling ...
The U.S. Food and Drug Administration issued a draft guidance on Wednesday to help drug developers validate alternative methods that can be used in place of animal studies during early stages of drug ...
March 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday issued a draft guidance to help companies reduce ...
As the FDA released its draft guidance, the NIH said it will invest $150 million in human-based research to develop the tools ...
In other developments, the EPA updated emission standards for polyether polyols and declined to regulate 9 drinking-water ...
The FDA has released draft guidance aimed at helping drug developers shift away from traditional animal testing as the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results